See more : Global Health Limited (MEDANTA.NS) Income Statement Analysis – Financial Results
Complete financial analysis of Core Laboratories N.V. (CLB) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Core Laboratories N.V., a leading company in the Oil & Gas Equipment & Services industry within the Energy sector.
- Hyosung Corporation (004800.KS) Income Statement Analysis – Financial Results
- Terilogy Holdings Corporation (5133.T) Income Statement Analysis – Financial Results
- Howden Joinery Group Plc (HWDJF) Income Statement Analysis – Financial Results
- Bonesupport Holding AB (publ) (2B4.F) Income Statement Analysis – Financial Results
- NV Bekaert SA (BEKB.BR) Income Statement Analysis – Financial Results
Core Laboratories N.V. (CLB)
About Core Laboratories N.V.
Core Laboratories N.V. provides reservoir description and production enhancement services and products to the oil and gas industry in the United States, Canada, and internationally. It operates through Reservoir Description and Production Enhancement segments. The Reservoir Description segment includes the characterization of petroleum reservoir rock, reservoir fluid, and gas samples to enhance production and improve recovery of oil and gas from its clients' reservoirs. It offers laboratory-based analytical and field services to characterize properties of crude oil and oil delivered products; and proprietary and joint industry studies. The Production Enhancement segment provides services and products relating to reservoir well completions, perforations, stimulations, and production. It offers integrated diagnostic services to evaluate and monitor the effectiveness of well completions and to develop solutions to improve the effectiveness of enhanced oil recovery projects. In addition, the company markets and sells its products through a combination of sales representatives, technical seminars, trade shows, and print advertising, as well as through distributors. It operates approximately in 50 countries. The company was founded in 1936 and is based in Amstelveen, the Netherlands.
Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 | 1995 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 509.79M | 489.74M | 470.25M | 487.27M | 668.21M | 700.85M | 659.81M | 594.74M | 797.52M | 1.09B | 1.07B | 981.08M | 907.65M | 794.65M | 695.54M | 780.84M | 670.54M | 575.69M | 483.47M | 427.43M | 405.64M | 364.75M | 376.57M | 336.10M | 303.70M | 286.20M | 214.90M | 105.40M | 80.10M |
Cost of Revenue | 415.74M | 410.82M | 386.41M | 395.63M | 518.18M | 520.05M | 499.18M | 469.52M | 560.11M | 691.97M | 688.44M | 644.74M | 593.37M | 513.79M | 457.77M | 514.78M | 449.19M | 407.10M | 368.12M | 336.39M | 326.92M | 301.31M | 293.31M | 268.66M | 245.40M | 220.50M | 170.50M | 84.70M | 64.20M |
Gross Profit | 94.05M | 78.92M | 83.84M | 91.63M | 150.03M | 180.80M | 160.63M | 125.23M | 237.41M | 393.26M | 385.07M | 336.34M | 314.28M | 280.86M | 237.77M | 266.05M | 221.35M | 168.59M | 115.34M | 91.04M | 78.72M | 63.44M | 83.26M | 67.44M | 58.30M | 65.70M | 44.40M | 20.70M | 15.90M |
Gross Profit Ratio | 18.45% | 16.11% | 17.83% | 18.81% | 22.45% | 25.80% | 24.34% | 21.06% | 29.77% | 36.24% | 35.87% | 34.28% | 34.63% | 35.34% | 34.18% | 34.07% | 33.01% | 29.28% | 23.86% | 21.30% | 19.41% | 17.39% | 22.11% | 20.07% | 19.20% | 22.96% | 20.66% | 19.64% | 19.85% |
Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
General & Administrative | 40.26M | 38.12M | 44.17M | 34.03M | 48.02M | 62.91M | 47.74M | 39.39M | 49.73M | 45.66M | 51.99M | 43.19M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 15.93M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Selling & Marketing | -1.37M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 6.86M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
SG&A | 38.89M | 38.12M | 44.17M | 34.03M | 48.02M | 62.91M | 47.74M | 39.39M | 49.73M | 45.66M | 51.99M | 43.19M | 41.14M | 33.03M | 30.37M | 31.65M | 33.84M | 33.08M | 37.85M | 28.14M | 22.79M | 20.18M | 15.93M | 13.54M | 12.30M | 8.40M | 6.00M | 3.60M | 2.70M |
Other Expenses | 515.00K | -722.00K | 5.60M | -1.83M | -5.32M | 737.00K | -452.00K | 344.00K | -3.67M | -1.07M | 338.00K | 4.12M | 22.38M | 20.91M | 20.62M | 28.54M | 3.66M | 11.95M | 16.57M | 16.38M | 22.61M | 22.50M | 27.78M | 19.22M | 18.70M | 16.50M | 11.00M | 4.60M | 3.10M |
Operating Expenses | 39.41M | 37.40M | 44.17M | 34.03M | 48.02M | 62.91M | 47.74M | 39.39M | 49.73M | 45.66M | 51.99M | 43.19M | 63.53M | 53.94M | 50.99M | 60.19M | 37.50M | 45.03M | 54.41M | 44.52M | 45.40M | 42.68M | 43.71M | 32.76M | 31.00M | 24.90M | 17.00M | 8.20M | 5.80M |
Cost & Expenses | 455.15M | 448.21M | 430.59M | 429.67M | 566.21M | 582.96M | 546.92M | 508.91M | 609.84M | 737.62M | 740.43M | 687.92M | 656.89M | 567.73M | 508.76M | 574.97M | 486.69M | 452.13M | 422.54M | 380.91M | 372.32M | 343.99M | 337.02M | 301.41M | 276.40M | 245.40M | 187.50M | 92.90M | 70.00M |
Interest Income | 0.00 | 11.57M | 9.15M | 14.37M | 14.69M | 0.00 | 0.00 | 0.00 | 56.00K | 403.00K | 776.00K | 319.00K | 138.00K | 249.00K | 0.00 | 848.00K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Interest Expense | 13.43M | 11.57M | 9.15M | 14.37M | 14.69M | 13.33M | 10.73M | 11.57M | 12.38M | 10.60M | 9.32M | 8.82M | 10.90M | 15.84M | 15.52M | 6.43M | 0.00 | 0.00 | 0.00 | 0.00 | 7.92M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Depreciation & Amortization | 15.78M | 17.16M | 18.52M | 20.87M | 22.61M | 23.09M | 24.52M | 26.87M | 27.46M | 26.70M | 25.47M | 22.92M | 23.30M | 23.27M | 24.33M | 21.77M | 19.48M | 17.69M | 17.06M | 17.40M | 23.54M | 20.10M | 22.54M | 19.22M | 18.70M | 16.50M | 11.00M | 4.60M | 3.10M |
EBITDA | 70.42M | 58.69M | 63.78M | -56.50M | 119.29M | 141.71M | 134.49M | 114.32M | 188.53M | 373.23M | 358.89M | 316.54M | 271.47M | 247.72M | 210.60M | 231.66M | 203.32M | 141.25M | 77.99M | 63.66M | 56.16M | 40.52M | 62.09M | 53.75M | 39.16M | 57.01M | 41.70M | 17.10M | 13.20M |
EBITDA Ratio | 13.81% | 11.98% | 13.56% | 15.73% | 17.85% | 20.22% | 20.82% | 14.49% | 23.07% | 31.93% | 31.06% | 30.30% | 30.19% | 31.48% | 30.35% | 29.26% | 28.04% | 23.65% | 17.41% | 14.77% | 13.79% | 11.86% | 18.67% | 15.77% | 19.89% | 20.34% | 17.36% | 16.03% | 16.35% |
Operating Income | 54.64M | 41.52M | 45.26M | 55.77M | 96.68M | 118.62M | 112.44M | 86.18M | 161.07M | 346.53M | 333.42M | 297.28M | 250.75M | 226.93M | 186.78M | 206.71M | 183.85M | 123.56M | 60.93M | 46.51M | 33.32M | 20.76M | 36.58M | 34.69M | 27.30M | 40.80M | 27.40M | 12.50M | 10.10M |
Operating Income Ratio | 10.72% | 8.48% | 9.63% | 11.45% | 14.47% | 16.93% | 17.04% | 14.49% | 20.20% | 31.93% | 31.06% | 30.30% | 27.63% | 28.56% | 26.85% | 26.47% | 27.42% | 21.46% | 12.60% | 10.88% | 8.21% | 5.69% | 9.71% | 10.32% | 8.99% | 14.26% | 12.75% | 11.86% | 12.61% |
Total Other Income/Expenses | -13.43M | -11.57M | -9.15M | -14.37M | -14.69M | -13.33M | -8.26M | -11.57M | -12.38M | -10.60M | -9.32M | -8.82M | -11.91M | -17.78M | -15.52M | 1.55M | -2.55M | -5.81M | -14.29M | -8.28M | -5.07M | -5.38M | -7.92M | -8.31M | -8.56M | -3.92M | -2.60M | -1.30M | -2.80M |
Income Before Tax | 41.21M | 29.95M | 36.11M | -91.18M | 81.99M | 105.29M | 101.71M | 74.61M | 148.69M | 335.93M | 324.10M | 288.46M | 238.84M | 209.15M | 171.26M | 208.61M | 181.30M | 117.75M | 46.64M | 38.24M | 25.62M | 13.16M | 28.66M | 27.36M | 5.10M | 33.70M | 22.00M | 11.40M | 7.30M |
Income Before Tax Ratio | 8.08% | 6.12% | 7.68% | -18.71% | 12.27% | 15.02% | 15.41% | 12.54% | 18.64% | 30.96% | 30.19% | 29.40% | 26.31% | 26.32% | 24.62% | 26.72% | 27.04% | 20.45% | 9.65% | 8.95% | 6.32% | 3.61% | 7.61% | 8.14% | 1.68% | 11.77% | 10.24% | 10.82% | 9.11% |
Income Tax Expense | 4.19M | 10.30M | 15.89M | 5.90M | -12.29M | 25.45M | 18.61M | 10.75M | 33.76M | 77.31M | 80.91M | 71.85M | 54.20M | 63.75M | 57.16M | 65.00M | 60.19M | 35.09M | 14.93M | 10.22M | 6.92M | 5.53M | 8.02M | 8.21M | 1.70M | 10.10M | 6.60M | 3.70M | 2.20M |
Net Income | 36.68M | 19.45M | 19.73M | -97.07M | 101.98M | 79.53M | 83.13M | 63.90M | 114.85M | 257.49M | 242.81M | 216.07M | 184.68M | 144.92M | 113.60M | 143.60M | 121.11M | 82.66M | 31.21M | 12.29M | 18.70M | -9.06M | 20.63M | 19.15M | 3.40M | 20.00M | 15.40M | 7.70M | 4.20M |
Net Income Ratio | 7.19% | 3.97% | 4.19% | -19.92% | 15.26% | 11.35% | 12.60% | 10.74% | 14.40% | 23.73% | 22.62% | 22.02% | 20.35% | 18.24% | 16.33% | 18.39% | 18.06% | 14.36% | 6.46% | 2.88% | 4.61% | -2.48% | 5.48% | 5.70% | 1.12% | 6.99% | 7.17% | 7.31% | 5.24% |
EPS | 0.79 | 0.42 | 0.51 | -2.18 | 2.11 | 1.80 | 1.88 | 1.45 | 2.71 | 5.90 | 5.38 | 4.66 | 3.99 | 3.23 | 2.47 | 2.85 | 2.58 | 1.65 | 0.60 | 0.23 | 0.31 | -0.14 | 0.31 | 0.28 | 0.04 | 0.30 | 0.31 | 0.18 | 0.11 |
EPS Diluted | 0.77 | 0.42 | 0.50 | -2.16 | 2.10 | 1.79 | 1.88 | 1.45 | 2.68 | 5.77 | 5.28 | 4.54 | 3.82 | 3.00 | 2.43 | 2.74 | 2.48 | 1.54 | 0.56 | 0.22 | 0.30 | -0.14 | 0.30 | 0.27 | 0.04 | 0.29 | 0.30 | 0.17 | 0.11 |
Weighted Avg Shares Out | 46.68M | 46.33M | 46.01M | 44.48M | 44.36M | 44.21M | 44.15M | 43.48M | 42.38M | 43.64M | 45.10M | 46.35M | 46.29M | 44.83M | 45.94M | 46.02M | 47.07M | 50.31M | 52.08M | 53.79M | 60.42M | 66.35M | 66.15M | 64.78M | 62.90M | 58.45M | 50.32M | 43.43M | 40.00M |
Weighted Avg Shares Out (Dil) | 47.52M | 46.81M | 46.69M | 44.97M | 44.65M | 44.47M | 44.26M | 44.15M | 42.91M | 44.60M | 45.99M | 47.55M | 48.39M | 48.24M | 46.66M | 47.89M | 48.82M | 53.78M | 56.02M | 57.52M | 62.36M | 66.35M | 68.54M | 67.08M | 64.89M | 60.50M | 52.00M | 44.71M | 40.00M |
Core Laboratories (CLB) Tops Q2 Earnings Estimates
CORE LAB REPORTS SECOND QUARTER 2023 RESULTS
Core Laboratories (CLB) Earnings Expected to Grow: Should You Buy?
CORE LABORATORIES' SECOND QUARTER 2023 WEBCAST AT 7:30 A.M. CDT / 8:30 A.M.
Core Laboratories: Green Shoots, But Too Far Down The Road
Core Labs (CLB) Q1 Earnings & Sales Beat Estimates
Core Laboratories N.V. (CLB) Q1 2023 Earnings Call Transcript
Core Laboratories (CLB) Q1 Earnings and Revenues Surpass Estimates
Why Core Laboratories, Gran Tierra Energy, and NexTier Oilfield Solutions Rallied Today
Oil & Gas Service Firms Hit by Stalling Activity Levels in Q1
Source: https://incomestatements.info
Category: Stock Reports